🇺🇸 FDA
Pipeline program

Solriamfetol

Jazz BED

Approved small_molecule active

Quick answer

Solriamfetol for Binge Eating Disorder is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Binge Eating Disorder
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials